This site is intended for healthcare professionals

A collection of journals on a pink background

Your reading list

Find all your bookmarked pages here...

Bookmarks

Blue test tubes arranged in a line, disappearing into the background

Sarclisa Quadruplets Show Benefits in NDMM

8 mins

Blue test tubes arranged in a line, disappearing into the background

Polivy Confirmed as New Standard for Lymphoma

2 mins

Blue test tubes arranged in a line, disappearing into the background

NICE UK Approves Elrexfio for Multiple Myeloma

1 mins

Blue test tubes arranged in a line, disappearing into the background

Updated Positive Data on MAAT-013 at ASH 2024

1 mins

Blue test tubes arranged in a line, disappearing into the background

Protara's Phase II trial of TARA-002 shows positive results in NMIBC

2 mins

Blue test tubes arranged in a line, disappearing into the background

ASH: Data on warm autoimmune hemolytic anemia burden

3 mins

Blue test tubes arranged in a line, disappearing into the background

Calquence + venetoclax improves survival in untreated CLL

2 mins

Blue test tubes arranged in a line, disappearing into the background

New ASH results: subcutaneous epcoritamab for lymphoma

5 mins

Blue test tubes arranged in a line, disappearing into the background

Kisqal + endocrine therapy reduces recurrence in HER+/HER2- EBC

1 mins

Blue test tubes arranged in a line, disappearing into the background

Tyvyt and Elunate combo approved for endometrial cancer in China

1 mins

Blue test tubes arranged in a line, disappearing into the background

Tonix submits NDA for non-narcotic fibromyalgia pain relief

1 mins

Blue test tubes arranged in a line, disappearing into the background

STRIDES Phase II study of azelaprag for obesity is discontinued

1 mins

Blue test tubes arranged in a line, disappearing into the background

Carvykti infusion improves minimal residual disease in myeloma

2 mins

Blue test tubes arranged in a line, disappearing into the background

Blincyto + chemo boosts survival in pediatric B-ALL

3 mins

Blue test tubes arranged in a line, disappearing into the background

ENERGIZE-T: Positive results for mitapivat in thalassemia

3 mins

Blue test tubes arranged in a line, disappearing into the background

TEMPO-2: Positive results for tavapadon in early Parkinson's

3 mins

Blue test tubes arranged in a line, disappearing into the background

KEYLYNK-001: Keytruda + chemo, Lynparza for BRCA ovarian cancer.

1 mins

Systematic review-based guideline “Parkinson’s disease” of the German Society of Neurology: diagnostic use of transcranial sonography

1 mins

Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care

1 mins

Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology

1 mins

German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions

1 mins

Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

1 mins

Physical therapist management of Parkinson Disease: A clinical practice guideline from the American Physical Therapy Association

1 mins

European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies

2 mins

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

1 mins

Blue test tubes arranged in a line, disappearing into the background

Phase III data: ACCESS-1 trial of pozelimab + cemdisiran vs. ravulizumab in paroxysmal nocturnal hemoglobinuria

4 mins

Blue test tubes arranged in a line, disappearing into the background

Longer term results from phase IIIASC4FIRST trial with Scemblix (asciminib) showing superior major molecular response (MMR) rates at week 96

1 mins

Migraine treatment: Position paper of the French Headache Society

1 mins

International Headache Society global practice recommendations for preventive pharmacological treatment of migraine

1 mins

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

1 mins

Blue test tubes arranged in a line, disappearing into the background

Long term data from ongoing X-TOLE open-label extension (OLE) study of azetukalner in patients with focal onset seizures.- Xenon Pharmaceuticals

4 mins

Blue test tubes arranged in a line, disappearing into the background

Results from phase III POD1UM-304 trial of Zynyz ( retifanlimab ) + chemotherapy in NSCLC.- Incyte Inc.

2 mins

Blue test tubes arranged in a line, disappearing into the background

Datopotamab Deruxtecan Demonstrated Meaningful Clinical Activity in Patients with Previously Treated Advanced EGFR- Mutated Non-Small Cell Lung Cancer in TROPION-Lung05 and TROPION-Lung01 Pooled Analysis- Daiichi Sankyo

2 mins

Blue test tubes arranged in a line, disappearing into the background

Partner Therapeutics to market Bizengri ( zenocutuzumab) in the United States- Merus N.V. and Partner Therapeutics

1 mins

Blue test tubes arranged in a line, disappearing into the background

MHRA (UK) approves Anzupgo (delgocitinib) cream for the treatment of adult patients with moderate to severe chronic hand eczema.- Leo Pharma

1 mins

Blue test tubes arranged in a line, disappearing into the background

New phase IIIB data shows Fabhalta (iptacopan) improved hemoglobin levels in adult patients with paroxysmal nocturnal hemoglobinuria who switched from anti-C5 therapy

1 mins

Latest industry news

Muna Therapeutics to collaborate with GSK to identify new drug targets for Alzheimer's disease

1 mins

Blue test tubes arranged in a line, disappearing into the background

FDA approval of Bizengri (zenocutuzumab-zbco) for NRG1+ pancreatic adenocarcinoma and NRG1+ non–small cell lung cancer (NSCLC)

2 mins

Blue test tubes arranged in a line, disappearing into the background

FDA accepts supplemental BLA for Columvi (glofitamab) + chemotherapy combination for people with relapsed or refractory diffuse large B-cell lymphoma- Roche

1 mins

Blue test tubes arranged in a line, disappearing into the background

Iinitiation of a phase III MOVe-NOW clinical trial to evaluate Lagrvrio (molnupiravir), for the treatment of adults with COVID-19 at high risk for disease progression

2 mins

Blue test tubes arranged in a line, disappearing into the background

Imfinzi (durvalumab) approved in the US as first and only immunotherapy regimen for patients with limited-stage small cell lung cancer

2 mins

Gastrointestinal challenges in nephropathic cystinosis: clinical perspectives

1 mins

Nephropathic cystinosis: an update on genetic conditioning

1 mins

Blue test tubes arranged in a line, disappearing into the background

GSK enters an option agreement to acquire rights to DB 1324 from Duality Biologics

1 mins

Blue test tubes arranged in a line, disappearing into the background

First single-dose medicine for P. vivax malaria prequalified by WHO and included in WHO Guidelines

2 mins

Blue test tubes arranged in a line, disappearing into the background

Coherus BioSciences sells Udenyca (pegfilgrastim-cbqv) franchise to Intas Pharmaceuticals

1 mins

Blue test tubes arranged in a line, disappearing into the background

FDA approves Yesintek (ustekinumab-kfce), a biosimilar to the reference product, Stelara (ustekinumab)

1 mins

Blue test tubes arranged in a line, disappearing into the background

Supplemental NDA submitted to FDA for Caplyta (lumateperone) for the treatment of Major Depressive Disorder

1 mins

Blue test tubes arranged in a line, disappearing into the background

Novartis acquires PTC 518 an HTT mRNA splice modulator for Huntington's disease from PTC Therapeutics

1 mins

Blue test tubes arranged in a line, disappearing into the background

Phase II study of namilumab, an investigational anti-GM-CSF monoclonal antibody failed to show a treatment benefit for chronic active pulmonary sarcoidosis

2 mins

Events

Blue background, white Text, Text: AAD, American, Academy of Dermatology Association

2025 AAD Annual Meeting

1 mins

EHSF 2025 – Dynamics in HS

1 mins

1 mins

15th Biosimilars & Biologics Global Congress 2024 Europe

1 mins

Reproductive Endocrinology 2024

1 mins

WCPGHAN 2024 Congress

1 mins

WORLDSymposium 2025

1 mins

You may be interested In

Systematic review-based guideline “Parkinson’s disease” of the German Society of Neurology: diagnostic use of transcranial sonography

1 mins

Guideline “Parkinson’s disease” of the German Society of Neurology (Deutsche Gesellschaft für Neurologie): concepts of care

1 mins

Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline “Parkinson’s disease” of the German Society of Neurology

1 mins

German Society of Neurology guidelines for the diagnosis and treatment of cognitive impairment and affective disorders in people with Parkinson’s disease: new spotlights on diagnostic procedures and non-pharmacological interventions

1 mins

Pharmacotherapy of motor symptoms in early and mid-stage Parkinson’s disease: guideline “Parkinson’s disease” of the German Society of Neurology

1 mins

Physical therapist management of Parkinson Disease: A clinical practice guideline from the American Physical Therapy Association

1 mins

European Academy of Neurology/Movement Disorder Society - European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies

2 mins

Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

1 mins

Migraine treatment: Position paper of the French Headache Society

1 mins

International Headache Society global practice recommendations for preventive pharmacological treatment of migraine

1 mins

International Headache Society global practice recommendations for the acute pharmacological treatment of migraine

1 mins